Leo Pharma Files For Approval Of Psoriasis Combination Drug In Japan
This article was originally published in PharmAsia News
Executive Summary
Leo Pharma has applied for the approval of a combination agent for the treatment of psoriasis in Japan, the company announced Aug. 23.